<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(8)</volume><submitter>Bornemann L</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Antigen rapid diagnostic tests (Ag-RDTs) play an important role in the diagnosis of SARS-CoV-2. They are easier, quicker, and less expensive than the 'reference standard' RT-PCR and therefore widely in use. Reliable clinical data with respect to Ag-RDT performance in SARS-CoV-2 Omicron variants of concern (VOCs) are limited. Consequently, the objective of this study was to determine the impact different VOCs-especially Omicron-have on the clinical performance of an Ag-RDT.&lt;h4>Methods&lt;/h4>We compared the clinical performance of the Sofia SARS-CoV-2 Ag-RDT to RT-PCR in a real-world, single-centre study in a clinical point-of-care setting in patients admitted to a large hospital via the emergency department from 2 November 2020 to 4 September 2022.&lt;h4>Results&lt;/h4>Among 38 4</pubmed_abstract><journal>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</journal><pagination>1085.e1-1085.e8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10181871</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern.</pubmed_title><pmcid>PMC10181871</pmcid><pubmed_authors>Hoyer A</pubmed_authors><pubmed_authors>Bornemann L</pubmed_authors><pubmed_authors>Kleideiter J</pubmed_authors><pubmed_authors>Ruprecht B</pubmed_authors><pubmed_authors>Wehmeier M</pubmed_authors><pubmed_authors>Kaup O</pubmed_authors><pubmed_authors>Bornemann R</pubmed_authors><pubmed_authors>Panning M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern.</name><description>&lt;h4>Objectives&lt;/h4>Antigen rapid diagnostic tests (Ag-RDTs) play an important role in the diagnosis of SARS-CoV-2. They are easier, quicker, and less expensive than the 'reference standard' RT-PCR and therefore widely in use. Reliable clinical data with respect to Ag-RDT performance in SARS-CoV-2 Omicron variants of concern (VOCs) are limited. Consequently, the objective of this study was to determine the impact different VOCs-especially Omicron-have on the clinical performance of an Ag-RDT.&lt;h4>Methods&lt;/h4>We compared the clinical performance of the Sofia SARS-CoV-2 Ag-RDT to RT-PCR in a real-world, single-centre study in a clinical point-of-care setting in patients admitted to a large hospital via the emergency department from 2 November 2020 to 4 September 2022.&lt;h4>Results&lt;/h4>Among 38 4</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-06-28T03:05:14.899Z</modification><creation>2024-12-04T08:12:04.405Z</creation></dates><accession>S-EPMC10181871</accession><cross_references><pubmed>37182639</pubmed><doi>10.1016/j.cmi.2023.05.009</doi></cross_references></HashMap>